MedPath

Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?

Completed
Conditions
Periprosthetic Joint Infection (PJI)
Interventions
Other: data collection to classify infection status
Registration Number
NCT05117671
Lead Sponsor
University Hospital, Basel, Switzerland
Brief Summary

This retrospective multi-center, multi-national cohort study is to validate the European Bone and Joint Infection Society (EBJIS) Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).

Detailed Description

Periprosthetic joint infection (PJI) is a major burden for healthcare systems. The European Bone and Joint Infection Society (EBJIS) proposed a new set of criteria introducing a three level 'traffic light' distinction: Infection Unlikely, Infection Confirmed but also an intermediate group called Infection Likely (but nor confirmed). This retrospective multi-center, multi-national cohort study is to validate the EBJIS Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1554
Inclusion Criteria
  • THA/TKA patients that underwent revision surgery regardless of final aseptic vs. infected diagnosis between 01.01.2013 until 31.12.2018
Exclusion Criteria
  • less than two years follow up
  • less than four intraoperative microbiology samples (synovial fluid, tissue samples, implant sonication)
  • no preoperative/intraoperative synovial fluid differential leukocyte count

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
revision total hip or knee arthroplastiesdata collection to classify infection statusTHA/TKA patients that underwent revision surgery between 01.01.2013 until 31.12.2018
Primary Outcome Measures
NameTimeMethod
Prosthetic Joint Infections (with or without the need for further surgery)since 01.01.2013 with a minimum of two years follow up

Number of Prosthetic Joint Infections (with or without the need for further surgery) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).

Need for Revision Surgerysince 01.01.2013 with a minimum of two years follow up

Number of Revision Surgeries (for all causes, PJI and aseptic failure) according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).

Survival rates of different subgroups among each PJI definitionsince 01.01.2013 with a minimum of two years follow up

Survival rates of different subgroups among each PJI definition ("Infection Unlikely", "Infection Confirmed", "Infection Likely (but nor confirmed)"

Survival rates between different definitionssince 01.01.2013 with a minimum of two years follow up

Survival rates between different classifications (EBJIS, MSIS/ICM 2013, ICM 2018).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

University Hospital Basel, Orthopedics and Traumatology

🇨🇭

Basel, Switzerland

Centro Hospitalar do Porto, Porto, Portugal

🇵🇹

Porto, Portugal

© Copyright 2025. All Rights Reserved by MedPath